Cardiovascular Diseases Clinical Trial
Official title:
Impact of Lifestyle Modification on Prevention of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population: Cluster Randomized Controlled Trial
Verified date | May 2017 |
Source | Sanpasitthiprasong Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a community-based cluster randomized control trial aimed to investigate the impact of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in mixed urban-rural areas of Ubon Ratchathani.
Status | Active, not recruiting |
Enrollment | 3600 |
Est. completion date | August 2027 |
Est. primary completion date | March 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 45 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Thai nationality - Age 45-75 years - Have resided in the Ubon Ratchathani's villages for at least 1 year - Those giving written informed consent to participate in the research project Exclusion Criteria: - Known case of dementia, chronic kidney disease, diabetes, chronic obstructive pulmonary disease, cancers and cardiovascular disease - Unable to communicate well in Thai - Unable to move or get physical exercise - Those at risk of having complications from performing physical exercise - Those diagnosed with cancers of any system/ organ or those in the end of life period |
Country | Name | City | State |
---|---|---|---|
Thailand | Sanpasitthiprasong Hospital | Muaeng | Ubon Ratchathani |
Lead Sponsor | Collaborator |
---|---|
Sanpasitthiprasong Hospital | Dementia Association of Thailand, Diabetes Association of Thailand, Nephrology Society of Thailand, Thai Dietetic Society, The Endocrine Society of Thailand, Ubon Ratchathani Public Health Office, Thailand |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Physical activity levels | Physical activity levels assessed using the global physical activity questionnaire (GPAQ) | 1, 2, 5 and 10 years | |
Other | Diet | Diet assessed by 24 hour food recall | 1, 2, 5 and 10 years | |
Other | Prevalence of current smokers | Percentage of current smokers in the study samples | 1, 2, 5 and 10 years | |
Other | Prevalence of alcohol consumption | Percentage of those who report alcohol consumption | 1, 2, 5 and 10 years | |
Other | Cognitive function | Cognitive function assessed by MMSE score | 2, 5 and 10 years | |
Primary | Dementia | Number of participants with dementia. Incident dementia will be diagnosed by medical specialists (Neuro-Med) following a battery of screening tests, including mini-mental state exam, depression and clock drawing tests. | 10 years | |
Secondary | Type 2 diabetes mellitus | Number of participants with type 2 diabetes mellitus. Diabetes mellitus is biochemically and clinically diagnosed. | 3, 5 and 10 years | |
Secondary | Cardiovascular disease | Number of participants with cardiovascular disease. Clinical diagnosis of cardiovascular disease. Diagnostic information will be obtained from medical records review and service reimbursement data. | 5 and 10 years | |
Secondary | Cancers | Number of participants with cancers. Diagnostic information will be obtained from medical records review and service reimbursement data. | 5 and 10 years | |
Secondary | Chronic obstructive pulmonary disease | Number of participants with physician-diagnosed chronic obstructive pulmonary disease. Diagnostic information will be obtained from medical records review and service reimbursement data. | 5 and 10 years | |
Secondary | Mortality | All-cause mortality retrieved from death certificate database, which captures deaths nationwide, dates of death and related causes. | 5 and 10 years | |
Secondary | Blood sugar | Blood sugar assessed as fasting plasma glucose and glycated hemoglobin (HbA1c) | 1, 2, 5 and 10 years | |
Secondary | Blood lipids | Blood lipids include total, LDL- and HDL-cholesterol and triglyceride | 1, 2, 5 and 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|